Skip to content
10-K

Annual Report

HALOZYME THERAPEUTICS, INC. HALO

0001159036-26-000024

← back to feed
Filed
Feb 17, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 10, 2026 118.02M sh
Shares Diluted FY 2025 · Dec 31, 2025 123.9M sh
Shares Diluted FY 2025 · Dec 31, 2024 129.42M sh
Shares Diluted FY 2025 · Dec 31, 2023 134.2M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $342.37M
Stock Repurchased FY 2025 · Dec 31, 2024 $250M
Stock Repurchased FY 2025 · Dec 31, 2023 $402.38M
Capex FY 2025 · Dec 31, 2025 $6.97M
Capex FY 2025 · Dec 31, 2024 $10.7M
Capex FY 2025 · Dec 31, 2023 $15.29M
Operating Cash Flow FY 2025 · Dec 31, 2025 $651.56M
Operating Cash Flow FY 2025 · Dec 31, 2024 $479.06M
Operating Cash Flow FY 2025 · Dec 31, 2023 $388.57M
Long Term Debt FY 2025 · Dec 31, 2025 $2.14B
Long Term Debt FY 2025 · Dec 31, 2024 $1.51B
Short Term Debt FY 2025 · Dec 31, 2025 $0
Cash And Equivalents FY 2025 · Dec 31, 2025 $133.82M
Cash And Equivalents FY 2025 · Dec 31, 2024 $115.85M
Cash And Equivalents FY 2025 · Dec 31, 2023 $118.37M
Stockholders Equity FY 2025 · Dec 31, 2025 $48.81M
Stockholders Equity FY 2025 · Dec 31, 2024 $363.82M
Stockholders Equity FY 2025 · Dec 31, 2023 $83.81M
Stockholders Equity FY 2025 · Dec 31, 2022 $169.8M
Current Liabilities FY 2025 · Dec 31, 2025 $177.09M
Current Liabilities FY 2025 · Dec 31, 2024 $139.1M
Total Liabilities FY 2025 · Dec 31, 2025 $2.48B
Total Liabilities FY 2025 · Dec 31, 2024 $1.7B
Current Assets FY 2025 · Dec 31, 2025 $825.21M
Current Assets FY 2025 · Dec 31, 2024 $1.09B
Total Assets FY 2025 · Dec 31, 2025 $2.53B
Total Assets FY 2025 · Dec 31, 2024 $2.06B
Eps Diluted FY 2025 · Dec 31, 2025 $2.56
Eps Diluted FY 2025 · Dec 31, 2024 $3.43
Eps Diluted FY 2025 · Dec 31, 2023 $2.10
Eps Basic FY 2025 · Dec 31, 2025 $2.64
Eps Basic FY 2025 · Dec 31, 2024 $3.50
Eps Basic FY 2025 · Dec 31, 2023 $2.13
Sga Expense FY 2025 · Dec 31, 2025 $207.09M
Sga Expense FY 2025 · Dec 31, 2024 $154.34M
Sga Expense FY 2025 · Dec 31, 2023 $149.18M
Net Income FY 2025 · Dec 31, 2025 $316.89M
Net Income FY 2025 · Dec 31, 2024 $444.09M
Net Income FY 2025 · Dec 31, 2023 $281.59M
Operating Income FY 2025 · Dec 31, 2025 $469.01M
Operating Income FY 2025 · Dec 31, 2024 $551.48M
Operating Income FY 2025 · Dec 31, 2023 $337.57M
Cost Of Revenue FY 2025 · Dec 31, 2025 $228.77M
Cost Of Revenue FY 2025 · Dec 31, 2024 $159.42M
Cost Of Revenue FY 2025 · Dec 31, 2023 $192.36M
Revenue FY 2025 · Dec 31, 2025 $1.4B
Revenue FY 2025 · Dec 31, 2024 $1.02B
Revenue FY 2025 · Dec 31, 2023 $829.25M